Taxoprexin Treatment for Advanced Skin Melanoma

NCT00249262 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Taxoprexin

Sponsor

American Regent, Inc.